Company Analysis

Moderna, Inc. (MRNA)

Nasdaq: MRNA · Biological Products, (No Diagnostic Substances) · Cambridge, MA · filing with the SEC since 2016
Grade5.7
◀ Past 7.3● Present 6.0▶ Future 3.6
1 est.

Filings

272 filings since 2017 beside 1,229 insider forms · Large accelerated filer · read from EDGAR on Nov 13, 2026
Due nextLarge accelerated filer
10-K Annual report for the fiscal year ending Dec 31, 2026Large accelerated filers have 60 days after the fiscal year ends. by Mar 1, 2027
10-Q Quarterly report for the quarter ending Mar 31, 2027Large accelerated filers have 40 days after the quarter ends; quarter ends are taken to the month end. by May 10, 2027

A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 37 days after the quarter ended. The proxy statement was last filed Mar 16, 2026.

Filings a yearinsider forms included
5929331721320118085104
20192020202120222023202420252026

2026 counts to Nov 13, 2026.

Officer or director change (8-K item 5.02): 5 times in the last 36 months, the newest Sep 30, 2026.
Insider forms 1,229

Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.

FiledFormWhat it is, in plain wordsPeriodAsk
Nov 6, 2026 10-Q Quarterly report Sep 30, 2026
Nov 6, 2026 8-K items 2.02, 9.01 Results released · Current report
Nov 5, 2026 SCHEDULE 13G/A Large holder update, amended
Sep 30, 2026 8-K items 5.02, 7.01, 9.01 Officer or director change; Investor disclosure (Regulation FD) · Current report
Sep 1, 2026 8-K items 1.01, 2.03, 3.02, 8.01, 9.01 Major agreement signed; New debt or obligation taken on; Shares sold without registration; Other event · Current report Aug 27, 2026
Aug 12, 2026 SCHEDULE 13G Large holder notice
Aug 6, 2026 SCHEDULE 13G/A Large holder update, amended
Jul 31, 2026 10-Q Quarterly report Jun 30, 2026
Jul 31, 2026 8-K items 2.02, 9.01 Results released · Current report
Jul 24, 2026 SCHEDULE 13G/A Large holder update, amended
Jul 8, 2026 8-K items 5.02, 7.01, 9.01 Officer or director change; Investor disclosure (Regulation FD) · Current report Jul 6, 2026
May 11, 2026 8-K items 5.03, 5.07, 9.01 Charter, bylaw or fiscal-year change; Shareholder vote · Current report May 6, 2026
May 1, 2026 10-Q Quarterly report Mar 31, 2026
May 1, 2026 8-K items 2.02, 9.01 Results released · Current report
Apr 30, 2026 SCHEDULE 13G Large holder notice
Mar 27, 2026 SCHEDULE 13G/A Large holder update, amended
Mar 16, 2026 DEFA14A Extra proxy material
Mar 16, 2026 DEF 14A Proxy statement May 6, 2026
Mar 16, 2026 ARS Annual report to shareholders Dec 31, 2025
Mar 5, 2026 8-K item 1.01 Major agreement signed · Current report Mar 3, 2026
Feb 20, 2026 S-8 Employee stock plan registration
Feb 20, 2026 10-K Annual report Dec 31, 2025
Feb 13, 2026 8-K items 2.02, 9.01 Results released · Current report
Feb 11, 2026 8-K items 7.01, 8.01, 9.01 Investor disclosure (Regulation FD); Other event · Current report Feb 3, 2026
Feb 9, 2026 SCHEDULE 13G/A Large holder update, amended
Feb 6, 2026 SCHEDULE 13G/A Large holder update, amended
Feb 5, 2026 SCHEDULE 13G Large holder notice
Jan 12, 2026 8-K items 2.02, 7.01, 9.01 Results released; Investor disclosure (Regulation FD) · Current report
Jan 5, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Dec 16, 2025 SC TO-I/A Issuer tender offer, amended
Nov 24, 2025 8-K items 1.01, 2.03, 9.01 Major agreement signed; New debt or obligation taken on · Current report Nov 19, 2025
Nov 20, 2025 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Nov 18, 2025 SC TO-I/A Issuer tender offer, amended
Nov 13, 2025 8-K item 5.07 Shareholder vote · Current report Nov 12, 2025
Nov 13, 2025 SC TO-I Issuer tender offer
Nov 12, 2025 SC TO-C Tender offer communication
Nov 6, 2025 10-Q Quarterly report Sep 30, 2025
Nov 6, 2025 8-K items 2.02, 9.01 Results released · Current report
Nov 6, 2025 SC TO-C Tender offer communication
Nov 5, 2025 SCHEDULE 13G/A Large holder update, amended
40 of 272 shown

Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.

SI Assistanton MRNA · research, not advice